Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26036283 | 0.79 | CYP1A2 (0.37) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL7657320 | 0.78 | CYP1A2 (0.50) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL30688302 | 0.77 | CYP1A2 (0.50) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL29101380 | 0.77 | CYP1A2 (0.50) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL26036288 | 0.77 | CYP1A2 (0.42) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL8653130 | 0.77 | CYP1A2 (0.48) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL11466569 | 0.76 | HPGD (0.39) | CYP1A2CYP2A6AKR1C3AKR1C2ALDH1A1 | |
| SCHEMBL4123235 | 0.75 | CYP1A2 (0.47) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL18800290 | 0.75 | CYP1A2 (0.47) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE | |
| SCHEMBL3949360 | 0.75 | CYP1A2 (0.47) | CYP1A2CYP2A6AKR1C3AKR1C2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20230131540-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY ELEMENT AND COMPOUND | DIC CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | CYP1A2 2601/4885CYP2A6 1463/4885AKR1C3 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.